204 related articles for article (PubMed ID: 29449896)
1. Myxofibrosarcoma primary cultures: molecular and pharmacological profile.
De Vita A; Recine F; Mercatali L; Miserocchi G; Liverani C; Spadazzi C; Casadei R; Bongiovanni A; Pieri F; Riva N; Amadori D; Ibrahim T
Ther Adv Med Oncol; 2017 Dec; 9(12):755-767. PubMed ID: 29449896
[TBL] [Abstract][Full Text] [Related]
2. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases.
Nascimento AF; Bertoni F; Fletcher CD
Am J Surg Pathol; 2007 Jan; 31(1):99-105. PubMed ID: 17197925
[TBL] [Abstract][Full Text] [Related]
3. Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives.
Vanni S; De Vita A; Gurrieri L; Fausti V; Miserocchi G; Spadazzi C; Liverani C; Cocchi C; Calabrese C; Bongiovanni A; Riva N; Mercatali L; Pieri F; Casadei R; Lucarelli E; Ibrahim T
Ther Adv Med Oncol; 2022; 14():17588359221093973. PubMed ID: 35782752
[TBL] [Abstract][Full Text] [Related]
4. Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line.
Miserocchi G; De Vita A; Mercatali L; Recine F; Liverani C; Spadazzi C; Pieri F; Riva N; Bongiovanni A; Casadei R; Fausti V; Ibrahim T
Cells; 2018 Oct; 7(11):. PubMed ID: 30366467
[TBL] [Abstract][Full Text] [Related]
5. Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need.
Vanni S; Fausti V; Fonzi E; Liverani C; Miserocchi G; Spadazzi C; Cocchi C; Calabrese C; Gurrieri L; Riva N; Recine F; Casadei R; Pieri F; Guerrieri AN; Serra M; Ibrahim T; Mercatali L; De Vita A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108089
[TBL] [Abstract][Full Text] [Related]
6. The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma.
Mentzel T; Brown LF; Dvorak HF; Kuhnen C; Stiller KJ; Katenkamp D; Fletcher CD
Virchows Arch; 2001 Jan; 438(1):13-22. PubMed ID: 11213831
[TBL] [Abstract][Full Text] [Related]
7. Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?
Lucarelli E; De Vita A; Bellotti C; Frisoni T; Vanni S; Guerrieri AN; Pannella M; Mercatali L; Gambarotti M; Duchi S; Miserocchi G; Maioli M; Liverani C; Ibrahim T
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958307
[TBL] [Abstract][Full Text] [Related]
8. Surgical margins do not affect prognosis in high grade myxofibrosarcoma.
Sambri A; Bianchi G; Righi A; Ferrari C; Donati D
Eur J Surg Oncol; 2016 Jul; 42(7):1042-8. PubMed ID: 27260849
[TBL] [Abstract][Full Text] [Related]
9. Biology and Management of High-Grade Myxofibrosarcoma: State of the Art and Future Perspectives.
Nishio J; Nakayama S
Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835765
[TBL] [Abstract][Full Text] [Related]
10. Grading in Myxofibrosarcoma of the Extremities Can Predict Survival and Local Control.
Sambri A; Tuzzato G; Spinnato P; De Paolis M; Donati DM; Bianchi G
Oncol Res Treat; 2020; 43(5):189-195. PubMed ID: 32268331
[TBL] [Abstract][Full Text] [Related]
11. Claudin 6 expression is useful to distinguish myxofibrosarcomas from other myxoid soft tissue tumors.
Bekki H; Yamamoto H; Takizawa K; Iwasaki T; Otsuka H; Yamada Y; Kohashi K; Harimaya K; Iwamoto Y; Oda Y
Pathol Res Pract; 2017 Jun; 213(6):674-679. PubMed ID: 28476380
[TBL] [Abstract][Full Text] [Related]
12. [Low malignancy myxofibrosarcoma versus low malignancy fibromyxoid sarcoma. Distinct entities with similar names but different clinical course].
Mentzel T; Katenkamp D; Fletcher CD
Pathologe; 1996 Mar; 17(2):116-21. PubMed ID: 8650138
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated mortality and prognostic factors in myxofibrosarcoma - A retrospective review of 109 patients.
Gilg MM; Sunitsch S; Leitner L; Bergovec M; Szkandera J; Leithner A; Liegl-Atzwanger B
Orthop Traumatol Surg Res; 2020 Oct; 106(6):1059-1065. PubMed ID: 32778437
[TBL] [Abstract][Full Text] [Related]
14. Fine-needle aspiration in myxofibrosarcoma: experience of Institut Curie.
Colin P; Lagacé R; Caillaud JM; Sastre-Garau X; Klijanienko J
Diagn Cytopathol; 2010 May; 38(5):343-6. PubMed ID: 19899126
[TBL] [Abstract][Full Text] [Related]
15. Treating Low-Grade Myxofibrosarcoma With Stereotactic Body Radiation Therapy Using CyberKnife®.
Mizumatsu S; Ryu H; Nomura K; Yoshikawa S; Inoue N
Cureus; 2021 Jul; 13(7):e16393. PubMed ID: 34408946
[TBL] [Abstract][Full Text] [Related]
16. Comparative Study of Myxofibrosarcoma With Undifferentiated Pleomorphic Sarcoma: Histopathologic and Clinicopathologic Review.
Yoshimoto M; Yamada Y; Ishihara S; Kohashi K; Toda Y; Ito Y; Yamamoto H; Furue M; Nakashima Y; Oda Y
Am J Surg Pathol; 2020 Jan; 44(1):87-97. PubMed ID: 31651522
[TBL] [Abstract][Full Text] [Related]
17. Does pre-operative MRI predict the risk of local recurrence in primary myxofibrosarcoma of the extremities?
Sambri A; Spinnato P; Bazzocchi A; Tuzzato GM; Donati D; Bianchi G
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e181-e186. PubMed ID: 31111597
[TBL] [Abstract][Full Text] [Related]
18. Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma.
Sun H; Liu J; Hu F; Xu M; Leng A; Jiang F; Chen K
Front Genet; 2023; 14():1109491. PubMed ID: 36873946
[TBL] [Abstract][Full Text] [Related]
19. Low-grade fibromyxoid sarcoma versus low-grade myxofibrosarcoma in the extremities and trunk. A comparison of clinicopathological and immunohistochemical features.
Oda Y; Takahira T; Kawaguchi K; Yamamoto H; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
Histopathology; 2004 Jul; 45(1):29-38. PubMed ID: 15228441
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous myxofibrosarcoma mimicking pleomorphic hyalinizing angiectatic tumor (PHAT): a potential diagnostic pitfall.
Mitsuhashi T; Barr RJ; Machtinger LA; Cassarino DS
Am J Dermatopathol; 2005 Aug; 27(4):322-6. PubMed ID: 16121054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
